New 2026 Cell and Gene Therapy Report Charts the Path from Scientific Progress to Patient Access

IRVING, Texas--(BUSINESS WIRE)--InspiroGene™ by McKesson today announced the publication of its third annual 2026 Cell and Gene Therapy Report.